Evaluate the Efficacy and Safety of DHA in the Adjuvant Treatment of Children With ASD.
NCT03620097
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
ASD
Interventions
DIETARY_SUPPLEMENT:
EuPoly-3 DHA Infant
OTHER:
Placebo
Sponsor
Maimónides Biomedical Research Institute of Córdoba